Filing Flows › Airsculpt Technologies (AIRS) › Guidance & outlook
Airsculpt Technologies (AIRS) guidance and outlook
Airsculpt Technologies (AIRS) lowered its guidance on Nov 6, 2026: Revenue $144M–$146M for FY2026; EBITDA $9.0M–$10.0M for FY2026. Airsculpt Technologies' 10-Q filed Nov 6, 2026 makes 5 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $144M–$146M | lowered |
| EBITDA | FY2026 | $9.0M–$10.0M | lowered |
From the earnings release filed Nov 6, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 6, 2026
- In addition to the measures presented in our condensed consolidated financial statements, we use the following key operational and business metrics to evaluate our business, measure our performance, develop financial forecasts and make strategic decisions:
- We recognize revenue based on the expected transaction price which is reduced for financing fees.
- If we are unable to realize the anticipated savings or benefits of our growth strategies, or otherwise fail to implement those strategies successfully, the operating results and liquidity may be adversely affected.
- We believe that the cash expected to be generated from operations will be sufficient for our working capital requirements, liquidity obligations, and payments due under our existing credit facilities for at least the next 12 months.
- As a result, only approximately half of the net cash proceeds we raised under our at-the-market offering program after August 7, 2026 per the Fourth Amendment will be available to fund our operations and other general corporate purposes.
Airsculpt Technologies' latest quarter
Airsculpt Technologies, Q3 2026: revenue $31.9M (-9% year over year), operating margin -13.0%, net loss $7.2M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
Questions
Did Airsculpt Technologies raise or lower its guidance?
Airsculpt Technologies (AIRS) lowered its guidance on Nov 6, 2026: Revenue $144M–$146M for FY2026; EBITDA $9.0M–$10.0M for FY2026.
What does Airsculpt Technologies expect?
In addition to the measures presented in our condensed consolidated financial statements, we use the following key operational and business metrics to evaluate our business, measure our performance, develop financial forecasts and make strategic decisions: We recognize revenue based on the expected transaction price which is reduced for financing fees. If we are unable to realize the anticipated savings or benefits of our growth strategies, or otherwise fail to implement those strategies successfully, the operating results and liquidity may be adversely affected.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.